Infectious Disease
Memoli JJ, Czajkowski L, Reed S, Bristol T, Proudfoot K, Fargis S, Stein M, Dunfee RL, Shaw PA, Taubenberger JK. Validation of a Wild-Type Influenza A Human Challenge Model: H1N1pdMIST, An A(H1N1)pdm09 Dose Finding IND Study. Clinical Infectious Diseases, 2015; 60(5): 693-702.
Memoli JJ, Czajkowski L, Reed S, Bristol T, Proudfoot K, Fargis S, Stein M, Dunfee RL, Shaw PA, Taubenberger JK. Validation of a Wild-Type Influenza A Human Challenge Model: H1N1pdMIST, An A(H1N1)pdm09 Dose Finding IND Study. Clinical Infectious Diseases, 2015; 60(5): 693-702.
Olivier KN, Shaw PA, Glaser TS, Bhattacharyya D, Fleshner M, Brewer CC, Zalewski CK, Folio LR, Seigelman JR, Shallom S, Park IK, Sampaio EP Zelazny AM, Holland SM, Prevots DR. Inhaled amikacin for treatment refractory pulmonary nontuberculous mycobacterial disease. Annals of the American Thoracic Society, 2014 Jan; 11(1):30-5.
Olivier KN, Shaw PA, Glaser TS, Bhattacharyya D, Fleshner M, Brewer CC, Zalewski CK, Folio LR, Seigelman JR, Shallom S, Park IK, Sampaio EP Zelazny AM, Holland SM, Prevots DR. Inhaled amikacin for treatment refractory pulmonary nontuberculous mycobacterial disease. Annals of the American Thoracic Society, 2014 Jan; 11(1):30-5.
Marques A, Telford SR, Turk S, Chung E, Williams C, Dardick K, Krause P, Brandeburg C, Crowder CD, Carolan HE, Eshoo MW, Shaw PA, Hu LT. Xenodiagnosis to detect Borrelia burgdorferi infection: A first-in-human study. Clinical Infectious Diseases, 2014: 58(7), 937-945.
Marques A, Telford SR, Turk S, Chung E, Williams C, Dardick K, Krause P, Brandeburg C, Crowder CD, Carolan HE, Eshoo MW, Shaw PA, Hu LT. Xenodiagnosis to detect Borrelia burgdorferi infection: A first-in-human study. Clinical Infectious Diseases, 2014: 58(7), 937-945. [PDF]
Lee M, Lee J, Carroll MW, Choi H, Min S, Song T, Via LE, Goldfeder LC, Kang E, Jin B, Park H, Kwak H, Kim H, Heon HS, Jeong I, Joh JS, Chen RY, Olivier KN, Shaw PA, Follmann D, Song SD, Lee JK, Lee DH, Kim CT, Dartois V, Park SK, Cho SN, Barry CE. Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis. New England Journal of Medicine, 2012 Oct 18; 367(16):1508-1518.
Lee M, Lee J, Carroll MW, Choi H, Min S, Song T, Via LE, Goldfeder LC, Kang E, Jin B, Park H, Kwak H, Kim H, Heon HS, Jeong I, Joh JS, Chen RY, Olivier KN, Shaw PA, Follmann D, Song SD, Lee JK, Lee DH, Kim CT, Dartois V, Park SK, Cho SN, Barry […]
Greenberg DE, Shoffner AR, Marshall-Batty KR, Arora K, Zhao M, Martin R, Ding L, Hammer CH, Shaw PA, Kuhns DB, Malech HL, Gallin JI, Zaramber KA, Holland SM. Serologic Reactivity to the Emerging Pathogen Granulibacter bethesdensis. Journal of Infectious Diseases. 2012 Sep 15;206(6):943-51.
Greenberg DE, Shoffner AR, Marshall-Batty KR, Arora K, Zhao M, Martin R, Ding L, Hammer CH, Shaw PA, Kuhns DB, Malech HL, Gallin JI, Zaramber KA, Holland SM. Serologic Reactivity to the Emerging Pathogen Granulibacter bethesdensis. Journal of Infectious Diseases. 2012 Sep 15;206(6):943-51.
Carroll MW, Lee M, Cai Y, Hallahan CW, Shaw PA, Min JH, Goldfeder LC, Alekseyev V, Grinkrug S, Kang HS, Hwang S, Park HM, Kang E, Lee SY, Jin B, Park HE, Min S, Park SK, Jeon DS, Via LE, Barry CE 3rd. Frequency of Adverse Reactions to First- and Second-line Anti-tuberculosis Chemotherapy in a Korean cohort. The International Journal of Tuberculosis and Lung Disease, 2012 Jul;16(7):961-6.
Carroll MW, Lee M, Cai Y, Hallahan CW, Shaw PA, Min JH, Goldfeder LC, Alekseyev V, Grinkrug S, Kang HS, Hwang S, Park HM, Kang E, Lee SY, Jin B, Park HE, Min S, Park SK, Jeon DS, Via LE, Barry CE 3rd. Frequency of Adverse Reactions to First- and Second-line Anti-tuberculosis Chemotherapy in a […]
Zarember KA, Marshall-Batty KR, Cruz AR, Chu J, Fenster ME, Shoffner AR, Rogge LS, Whitney AR, Czapiga M, Song HH, Shaw PA, Nagashima K, Malech HL, DeLeo FR, Holland SM, Gallin JI, Greenberg DE. Innate immunity against Granulibacter bethesdensis, an emerging Gram-negative bacterial pathogen, Infection and Immunity, 2012 Mar; 80 (3) 975-981.
Zarember KA, Marshall-Batty KR, Cruz AR, Chu J, Fenster ME, Shoffner AR, Rogge LS, Whitney AR, Czapiga M, Song HH, Shaw PA, Nagashima K, Malech HL, DeLeo FR, Holland SM, Gallin JI, Greenberg DE. Innate immunity against Granulibacter bethesdensis, an emerging Gram-negative bacterial pathogen, Infection and Immunity, 2012 Mar; 80 (3) 975-981.
Prevots DR, Shaw PA Strickland D, Jackson LA, Raebel MA, Blosky MA, Montes de Oca R, Shea YR, Seltz AE, Holland SM Olivier KN. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. American Journal of Respiratory Critical Care Medicine 2010 Oct 1; 182 (7): 970-6.
Prevots DR, Shaw PA Strickland D, Jackson LA, Raebel MA, Blosky MA, Montes de Oca R, Shea YR, Seltz AE, Holland SM Olivier KN. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. American Journal of Respiratory Critical Care Medicine 2010 Oct 1; 182 (7): 970-6. [PDF]
Shaw PA Combination versus monotherapy for septic shock patients [Commentary]. Critical Care Medicine. 2010 Sep; 38 (9): 1905-6.
Shaw PA Combination versus monotherapy for septic shock patients [Commentary]. Critical Care Medicine. 2010 Sep; 38 (9): 1905-6.
Komati S, Shaw PA, Stubbs N, Mathibedi MJ, Malan L, Metcalf JA, Masur H, Hassim S. Tuberculosis risk factors and mortality for HIV infected persons receiving antiretroviral therapy in South Africa. AIDS, 2010 Jul 31; 24 (12): 1849-55.
Komati S, Shaw PA, Stubbs N, Mathibedi MJ, Malan L, Metcalf JA, Masur H, Hassim S. Tuberculosis risk factors and mortality for HIV infected persons receiving antiretroviral therapy in South Africa. AIDS, 2010 Jul 31; 24 (12): 1849-55. [PDF]